# BIG Molecular Screening Feasibility Study

> **NCT02094742** · NA · COMPLETED · sponsor: **Jules Bordet Institute** · enrollment: 30 (estimated)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **PROCEDURE:** biopsy

## Key facts

- **NCT ID:** NCT02094742
- **Lead sponsor:** Jules Bordet Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02094742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02094742, "BIG Molecular Screening Feasibility Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02094742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*